Khiron Life Sciences (KHRN)

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Shorts lick their wounds in two healthcare stocks

Short sellers reduced their positions in two healthcare stocks which have shown up positively on INK screens over the past month. On February 22nd, we wrote that shorts had boosted their bets against Khiron Life Sciences (Mostly Sunny; KHRN) right before the stock soared to new all-time highs. According to the latest IIROC short report released March 21st, those bets have fallen dramatically.

Short positions have dropped by almost 1.5 million shares over the past month

Short bets jumped against Khiron Life Sciences right before stock soared

According to the latest IIROC report, short bets against Khiron Life Sciences (Sunny; KHRN) soared by a whopping 3,076,474 shares in the period between February 1st and 15th. That was right before the stock charged up to its all-time high of $4.33 (CXC trading - click here for latest real-time quote) set earlier today.

Click here for KHRN INK company page (INK subscription required)

While the recent jump may already be a result of a short-squeeze, there could be more upside to come.

Subscribe to RSS - Khiron Life Sciences (KHRN)